Toggle Main Menu Toggle Search

ePrints

The addition of oral idarubicin to a chlorambucil/dexamethasone combination has a significant impact on time to treatment failure but none on overall survival in patients with low grade non-Hodgkin's lymphoma: Results of the Scotland and Newcastle Lymphoma Group randomized NHL VIII trial

Lookup NU author(s): Dr Penelope Taylor, Dr Brian Angus, Professor Graham Jackson, Dr Helen Lucraft, Professor Stephen Proctor

Downloads

Full text for this publication is not currently held within this repository. Alternative links are provided below where available.


Publication metadata

Author(s): Taylor, P. R. A., White, J. M., Prescott, R. J., Angus, B., Galloway, M. J., Jackson, G. H., Lessells, A. M., Lucraft, H. H., Summerfield, G. P., Proctor, S. J.

Publication type: Article

Journal: Leukemia and Lymphoma

Year: 2006

Volume: 47

Issue: 11

Pages: 2321-2330

Print publication date: 01/11/2006

ISSN (print): 1042-8194

ISSN (electronic): 1029-2403

URL: http://dx.doi.org/10.1080/10428190600881256

DOI: 10.1080/10428190600881256

PubMed id: 17107904


Altmetrics

Altmetrics provided by Altmetric


Actions

    Link to this publication


Share